Lupin gets US health regulator approval for generic oral relief solution
Lupin Has Received The Green Signal From The US Health Regulator For Generic Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution Usedfor Providing Relief Of Cough.
Drug major Lupin has received the green signal from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution usedfor providing relief of cough.
The company has received US Food and Drug Administration (USFDA) approval for its generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution (Syrup) 5 mg/1.5 mg per 5 ml, Lupin said in a BSE filing.
The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in the same strength, it added.
Hydrocodone Bitartrate and Homatropine Methylbromide is indicated for the symptomatic relief of cough in adults and children 6 years of age and older.
Shares of Lupin Ltd today closed at Rs 1,440.15 per scrip on BSE, up 0.57 per cent from its previous close.
For all the Latest Business News, Companies & Commodities News, Download News Nation Android and iOS Mobile Apps.
More from Business
Take Control Of Your Financial Goals: Apply For A Personal Loan Now
Nihal Dangoria: An Indian Entrepreneur Making a Bright Future For The Real Estate Industry
Data breach incident at Extramarks highlights growing cybersecurity concerns in Indian companies
How is ePayLater empowering retailers across the country
Follow your heart, but don't ignore your mind When it comes to investing